Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
CONCLUSIONS: Both dosages of the HB vaccine were well tolerated and elicited a good immune response in infants of Group A, regardless of the maternal anti-HBs serostatus. EVE did not significantly differ between Groups B and C. Clinicaltrails.gov identifier: NCT02152709.
PMID: 26144895 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Kang G, Ma F, Chen H, Yang Y, Guo S, Wang Z, Liang X, Li L, Cui F, Zhang L Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Clinical Trials | Hepatitis | Hepatitis B | Hepatitis Vaccine | Pain | Perinatology & Neonatology | Vaccines